1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Thyroid Dysfunction and COVID-19: The Emerging Role of Selenium in This Intermingled Relationship, 2022, Gorini et al

Discussion in 'Epidemics (including Covid-19, not Long Covid)' started by Arnie Pye, Jun 15, 2022.

  1. Arnie Pye

    Arnie Pye Senior Member (Voting Rights)

    Messages:
    6,095
    Location:
    UK
    Title : Thyroid Dysfunction and COVID-19: The Emerging Role of Selenium in This Intermingled Relationship

    Link : https://www.researchgate.net/profil...elenium-in-This-Intermingled-Relationship.pdf

    Authors : Francesca Gorini 1, *, Laura Sabatino 1 , Alessio Coi 1, Giorgio Iervasi 1 and Cristina Vassalle 2,

    1 Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy; laura.sabatino@ifc.cnr.it (L.S.);
    alessio.coi@ifc.cnr.it (A.C.); iervasi@ifc.cnr.it (G.I.)
    2 Fondazione CNR-Regione Toscana Gabriele Monasterio, 56124 Pisa, Italy
    * Correspondence: fgorini@ifc.cnr.it (F.G.); cristina.vassalle@ftgm.it (C.V.

    Abstract:
    [with paragraphs added]

    COVID-19 represents a worldwide public health emergency, and, beyond the respiratory
    symptoms characterizing the classic viral disease, growing evidence has highlighted a possible
    reciprocal relationship between SARS-CoV-2 infection and thyroid dysfunction.

    The updated data discussed in this review suggests a role of SARS-CoV-2 infection on the thyroid gland, with multiple thyroid pictures described. Conversely, no conclusion can be drawn on the association between pre-existing thyroid disease and increased risk of SARS-CoV-2 infection.

    In this scenario, selenium (Se), an essential trace element critical for thyroid function and known as an effective agent against viral infections, is emerging as a potential novel therapeutic option for the treatment of COVID-19. Large multicentre cohort studies are required to elucidate the mechanisms underlying thyroid dysfunction during or following recovery from COVID-19, including Se status.

    Meanwhile, clinical trials should be performed to evaluate whether adequate intake of Se can help address COVID-19 in Se-deficient patients, also avoiding thyroid complications that can contribute to worsening outcomes during infection.
     

Share This Page